Wu, Tianshi David
Fawzy, Ashraf
Kinney, Gregory L.
Bon, Jessica
Neupane, Maniraj
Tejwani, Vickram
Hansel, Nadia N.
Wise, Robert A.
Putcha, Nirupama
McCormack, Meredith C. http://orcid.org/0000-0003-1702-3201
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (U01HL089897, U01HL089856, F32HL149258)
U.S. Department of Veterans Affairs (CIN 13-413)
National Institute of Environmental Health Sciences (P50ES018176)
National Institute on Minority Health and Health Disparities (P50MD010431)
U.S. Environmental Protection Agency (83615201, 83615001)
Article History
Received: 29 December 2020
Accepted: 8 February 2021
First Online: 26 February 2021
Ethics approval and consent to participate
: COPDGene was performed with local IRB authorization at all participating institutions. All participants gave written informed consent.
: Not applicable.
: NNH reports grants from the COPD Foundation, grants and personal fees from AstraZeneca and GlaxoSmithKline, grants from Boehringer Ingelheim, and personal fees from Mylan, unrelated to the submitted work. MCM reports royalties from UpToDate and personal fees from Aridis, GlaxoSmithKline, and Celgene, unrelated to the submitted work. RAW reports personal fees from AstraZeneca, Contrafect, Roche-Genentech, Merck, Verona, Mylan, Theravance, AbbVie, GSK, ChemRx, Kiniksa, Bristol Myers Squibb, Galderma, Kamada, Pulmonx, Kinevant, PureTech, Arrowhead, VaxArt, and Polarean, unrelated to the submitted work. TDW, AF, GLK, JB, MN, VT, and NP report no competing interests.